TREATMENT OF LIVER, BILE DUCT AND PANCREATIC DISORDERS Russian patent published in 2021 - IPC A61K38/04 A61K38/17 A61K38/26 A61P1/16 A61P1/18 A61P3/00 

Abstract RU 2740913 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to methods of treating or preventing disorders of the liver, bile ducts and pancreas. A method of treating or preventing a liver disease or disorder selected from a group consisting of toxic liver damage, alcoholic or non-alcoholic fatty liver disease (NAFLD), hepatic cirrhosis, hepatic insufficiency, hepatic fibrosis, liver sclerosis, hepatic encephalopathy, non-alcoholic steatohepatitis (NASH), wherein said method comprises administering an effective amount of α-defensin and/or β-defensin of mammals selected from a group consisting of hBD-2 (SEQ ID NO: 5), truncated hBD2 (SEQ ID NO: 17), hBD-1 (SEQ ID NO: 4), hBD-3 (SEQ ID NO: 6), and hBD-4 (SEQ ID NO: 7), β-defensin, which differs from hBD1, hBD2, hBD3, hBD4, or truncated hBD2 (SEQ ID NO: 17) by less than 5 conserved amino acid substitutions, HD5 (SEQ ID NO: 8), and/or HD6 (SEQ ID NO: 9), a subject in need thereof. Also disclosed are a method of treating or preventing a biliary disease or disorder, a method of treating or preventing a disease or a pancreatic disorder, method of treating or preventing a metabolic disease or disorder, using α-defensin and/or β-defensin in mammals in a method of treating and preparing a medicinal agent.

EFFECT: treatment of liver, bile duct and pancreatic disorders is offered.

35 cl, 38 dwg, 10 ex

Similar patents RU2740913C2

Title Year Author Number
METHODS FOR MODULATING INTESTINAL MICROBIOTA 2017
  • Nordkild, Peter
  • Wehkamp, Jan
  • Kjaerulff, Soren
RU2738265C2
COMPOSITIONS AND METHODS FOR CONTROLLING ACCUMULATION OF ADIPOSE TISSUE 2014
  • Vulf M. Majkl
  • Bojlan Majkl O.
RU2711478C2
COMPOSITION FOR PREVENTING, IMPROVING OR TREATING OBESITY OR FATTY LIVER DISEASE CONTAINING LEUCONOSTOC CITREUM WiKim0104 2020
  • Choj, Khak Jong
  • Lim, Seul-Ki
RU2816754C2
USE OF COMPOSITIONS CONTAINING BIFIDOBACTERIUM ANIMALIS SSP. LACTIS LMG P-28149 2015
  • Kentan Zhoan
  • Linart Van Lidt De Jede Ekhan
  • Granzhett Korinn
  • Po Bryuno
  • Makki Kassem
  • Volevchuk Izabell
  • Alar Zhann
  • Lerter-Valanti Veronik
RU2673341C2
FGF21 Fc FUNCTION PROTEIN, GLP-1 Fc FUNCTION PROTEIN AND COMBINED THERAPEUTIC AGENT INCLUDING THEM AND THEIR USE 2020
  • Dun, Chzhao
  • Chzhou, Chi
  • Chzhan, Tsziyu
  • Li, Yuanli
  • Li, Tsyan
RU2804335C2
STRAIN OF AKKERMANSIA MUCINIPHILA AND APPLICATION THEREOF 2019
  • Ko, Gwang Pyo
  • Yoon, Hyo Shin
  • Cho, Chung Hwan
  • You, Hyun Ju
  • Nam, Tae Wook
RU2777068C1
COMPOSITION FOR HYPERLIPIDEMIA TREATMENT CONTAINING OXYNTOMODULIN DERIVATIVE 2013
  • Chun Sun Yub
  • Kim Chin-Sun
  • Dzhan Myun Khyun
  • Li San Khyun
  • Chkhoj In Yung
  • Kvon Se Chan
RU2642267C2
AKKERMANSIA MUCINIPHILA STRAIN AND ITS APPLICATION 2019
  • Ko, Gwang Pyo
  • Yoon, Hyo Shin
  • Cho, Chung Hwan
  • You, Hyun Ju
  • Nam, Tae Wook
RU2792651C2
TREATMENT OF ABNORMAL VISCERAL FAT DEPOSITION WITH FIBROBLAST GROWTH FACTOR 3 (sFGFR3) SOLUBLE POLYPEPTIDES 2018
  • Guz, Elvire
  • Garsiya, Stefani
RU2794170C2
PHARMACEUTICAL COMPOSITION INCLUDING A POLYPEPTIDE 2019
  • Lee, Kang Choon
  • Park, Og Yi
  • An, Hyoung Tae
  • Park, Eun Ji
  • Shin, Jae Hee
  • Lim, Sung Mook
RU2777095C1

RU 2 740 913 C2

Authors

Nordkild, Peter

Kjaerulff, Soren

Dates

2021-01-21Published

2017-04-28Filed